Eun J. Nam

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 164 publications

PPP1R3C functions as a tumor suppressor in endometrial cancer through promotion of glycogen synthesis.

PPP1R3C functions as a tumor suppressor in endometrial cancer through promotion of glycogen synthesis.

Journal: BMB reports

Published: September 01, 2026

A multicenter study of laparoscopic versus laparotomic surgery in the treatment of stage I adult granulosa cell and Sertoli-Leydig cell tumors: (LARGES): Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3005).

A multicenter study of laparoscopic versus laparotomic surgery in the treatment of stage I adult granulosa cell and Sertoli-Leydig cell tumors: (LARGES): Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3005).

Journal: Gynecologic oncology

Published: April 17, 2026

PPP1R3C functions as a tumor suppressor in endometrial cancer through promotion of glycogen synthesis.

PPP1R3C functions as a tumor suppressor in endometrial cancer through promotion of glycogen synthesis.

Journal: BMB reports

Published: March 04, 2026

Impact of germline RAD51D mutations on breast cancer: Susceptibility to DNA-damaging agents.

Impact of germline RAD51D mutations on breast cancer: Susceptibility to DNA-damaging agents.

Journal: Molecular therapy. Oncology

Published: November 05, 2025

Cold coagulation revisited: a strategy for high-grade cervical intraepithelial neoplasia in reproductive-age women.

Cold coagulation revisited: a strategy for high-grade cervical intraepithelial neoplasia in reproductive-age women.

Journal: Obstetrics & gynecology science

Published: October 01, 2025

Comparison of oncologic outcomes between completion hysterectomy and no completion hysterectomy in patients who achieved complete response and completed childbearing after fertility-sparing treatment for early-stage endometrial cancer: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3001).

Comparison of oncologic outcomes between completion hysterectomy and no completion hysterectomy in patients who achieved complete response and completed childbearing after fertility-sparing treatment for early-stage endometrial cancer: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3001).

Journal: Gynecologic oncology

Published: August 14, 2025

Corrigendum to 'Changes in the tumor immune microenvironment during disease progression in clear cell ovarian cancer' [International Journal of Gynecological Cancer, Volume 34 Issue 11 (2024) 1780-1786].

Corrigendum to 'Changes in the tumor immune microenvironment during disease progression in clear cell ovarian cancer' [International Journal of Gynecological Cancer, Volume 34 Issue 11 (2024) 1780-1786].

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 05, 2025

Impact of clinical trial participation on the survival of patients with newly diagnosed advanced ovarian cancer.

Impact of clinical trial participation on the survival of patients with newly diagnosed advanced ovarian cancer.

Journal: Frontiers in oncology

Published: March 10, 2025

Is restaging surgery quintessential in suspected early-stage epithelial ovarian cancer? An ancillary study of the Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3002).

Is restaging surgery quintessential in suspected early-stage epithelial ovarian cancer? An ancillary study of the Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-3002).

Journal: Journal of gynecologic oncology

Published: January 21, 2025

Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines.

Clinical practice guidelines for cervical cancer: an update of the Korean Society of Gynecologic Oncology Guidelines.

Journal: Journal of gynecologic oncology

Published: December 30, 2024

Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian Cancer.

Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian Cancer.

Journal: Cancer research and treatment

Published: December 23, 2024

Modifying surgical extents in patients with preoperatively presumed early-stage endometrial cancer based on ProMisE classification: a retrospective, single-center study.

Modifying surgical extents in patients with preoperatively presumed early-stage endometrial cancer based on ProMisE classification: a retrospective, single-center study.

Journal: Journal of gynecologic oncology

Published: December 03, 2024

Showing 1-12 of 164

Last Updated: 09/26/2026